UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000051845
Receipt number R000059160
Scientific Title Effects of the test food on improving fatigue and muscle soreness
Date of disclosure of the study information 2023/08/08
Last modified on 2023/08/07 12:34:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of the test food on improving fatigue and muscle soreness

Acronym

Effects of the test food on improving fatigue and muscle soreness

Scientific Title

Effects of the test food on improving fatigue and muscle soreness

Scientific Title:Acronym

Effects of the test food on improving fatigue and muscle soreness

Region

Japan


Condition

Condition

Healthy participants

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the effects of test food on fatigue and muscle soreness

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Subjective degree of muscle soreness

Key secondary outcomes

Subjective degree of fatigue, muscle damage markers, inflammatory markers, stress markers, safety evaluation


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Oral intake of the test food (1 week)

Interventions/Control_2

Oral intake of the test food (1 week)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

25 years-old >

Gender

Male and Female

Key inclusion criteria

Healthy individuals who have an aerobic exercise habit

Key exclusion criteria

Individuals who have a medical history

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Tohru
Middle name
Last name Takemasa

Organization

University of Tsukuba

Division name

Institute of Health and Sport Sciences

Zip code

305-8574

Address

1-1-1 Tennodai, Tsukuba, Ibaraki, Japan

TEL

0298532762

Email

takemasa.tohru.gm@u.tsukuba.ac.jp


Public contact

Name of contact person

1st name Tohru
Middle name
Last name Takemasa

Organization

University of Tsukuba

Division name

Institute of Health and Sport Sciences

Zip code

305-8574

Address

1-1-1 Tennodai, Tsukuba, Ibaraki, Japan

TEL

029-853-2762

Homepage URL


Email

takemasa.tohru.gm@u.tsukuba.ac.jp


Sponsor or person

Institute

University of Tsukuba

Institute

Department

Personal name



Funding Source

Organization

NIPPN CORPORATION

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

University of Tsukuba

Address

1-1-1 Tennodai, Tsukuba, Ibaraki, Japan

Tel

029-853-2571

Email

hitorinri@un.tsukuba.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

筑波大学体育系


Other administrative information

Date of disclosure of the study information

2023 Year 08 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

26

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 09 Month 21 Day

Date of IRB

2022 Year 11 Month 08 Day

Anticipated trial start date

2022 Year 11 Month 01 Day

Last follow-up date

2023 Year 11 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 08 Month 07 Day

Last modified on

2023 Year 08 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000059160